SeaStar Medical Holding Corporation
ICU
$1.24
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.84% | 17.95% | 32.00% | -20.98% | -58.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.11% | 53.77% | 24.51% | -13.77% | -59.35% |
| Operating Income | -51.97% | -51.46% | -24.51% | 13.77% | 59.35% |
| Income Before Tax | 53.30% | 38.08% | -32.39% | -78.93% | -12.75% |
| Income Tax Expenses | 100.00% | -- | -40.00% | -- | -- |
| Earnings from Continuing Operations | 53.27% | 38.08% | -32.24% | -78.93% | -12.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.27% | 38.08% | -32.24% | -78.93% | -12.69% |
| EBIT | -51.97% | -51.46% | -24.51% | 13.77% | 59.35% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 85.34% | 87.85% | 74.96% | 65.27% | 67.51% |
| Normalized Basic EPS | 85.65% | 61.51% | 74.93% | 65.27% | 66.80% |
| EPS Diluted | 85.34% | 87.85% | 74.96% | 65.27% | 67.51% |
| Normalized Diluted EPS | 85.65% | 61.51% | 74.93% | 65.27% | 66.80% |
| Average Basic Shares Outstanding | 218.69% | 409.65% | 428.18% | 415.20% | 246.87% |
| Average Diluted Shares Outstanding | 218.69% | 409.65% | 428.18% | 415.20% | 246.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |